ERIKA MASIAS: Open Payments
NPI 1619337276 · HACKENSACK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,328 in 73 payments from 8 companies in 2025. Trend: 2023 $849 · 2024 $1,895 · 2025 $2,328
Food & beverage: $1,533Consulting: $795
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 8 | $997 |
| Biogen, Inc. | 4 | $314 |
| ABBVIE INC. | 34 | $312 |
| Axsome Therapeutics, Inc. | 8 | $278 |
| Celgene Corporation | 16 | $159 |
| Janssen Biotech, Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: VYEPTI, Symbravo, QULIPTA, TYSABRI, ZEPOSIA, TREMFYA, Wegovy, VUMERITY.
Industry payments across NJ — which companies pay providers there.
